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Several known eosinophil chemotactic factors are 
compared with regard to their biological behavior dur-
ing in vitro migration under agarose: zymosan activated 
serum (Zas), containing the chemotactic fragment C5a, 
the lymphokine eosinophil stimulation promoter (ESP), 
neutrophil-derived eosinophil chemotactic factor (ECF) 
and the N-formyl-methionyl-phenylalanine (NFMP) pep-
tide induced chemotaxis and chemokinesis of granulo-
cytes. All factors except NFMP attract eosinophils and 
neutrophils. ECF alone selectively enhances eosinophil 
migration, and NFMP is inactive towards eosinophils. 
ESP is the least potent factor but affects eosinophil 
migration over a prolonged period of time. These differ-
ent biological properties of the chemotactic factors may 
help to explain the differential influx of eosinophil and 
neutrophil leukocytes to tissue sites. 
During the past decade, investigators have tried to elucidate 
the role of eosinophils in inflammatory reactions and the mech-
anisms regulating their increased production and accumulation 
at tissue sites. Using different in vitro methods, several factors 
with eosinophil chemotactic properties have been described, 
but comparative data on their potency, their specificity and 
their ability to attract leukocytes are not available. Such data 
would, however, be important in order to understand why there 
are large nu~nbers of pure eosinophils in some tissue lesions and 
why these cells are few and admixed with several cell types in 
others. 
The aim of the present study was therefore to examine the 
properties of the 4 most well-known and best-characterized 
factors reported to cause in vitro eosinophil migration. They 
are the complement fragment C5a, present in zymosan-acti-
vated serum (Zas) [1], the neutrophil-derived eosinophil che-
motactic factor (ECF) [2], the lymphokine eosinophil stimula-
tion promoter (ESP) [3] and a synthetic analogue of bacterial 
factor [4], the n-formyl-methionyl-phenylalanine (NFMP) pep-
tide [5]. The factors are compared in the same experimental 
setup with regard to their G,hemotactic and chemokinetic activ-
ities, their target cell specificity and their selectivity for different 
?ell types. In addition, the kinetics of emigration of the respond-
mg cells are studied. Since, in the conventional Boyden che-
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motaxis method, cells are distorted and stimulated to degt'an-
ulate during migration through the narrow filter pores, and 
since it is therefore difficult to differentiate neutrophils from 
eosinophils, we selected instead two other techniques described 
more recently for comparative studies of the factors. In the one 
method, cells move over the surface of a tissue culture plate 
under agarose [6]. There is little distortion of their morphology, 
and the entire cell population can easily be differentiated and 
evaluated for its migratory behavior. In the other method, cells 
are incorporated directly into a microdroplet of agarose and 
covered by the fluid containing the chemoattractants to be 
tested [3]. While the latter method has the disadvantage of 
measuring both chemotaxis and chemokinesis, it is easy to 
perform and allows again an accurate assessment of the migra-
tory behavior of the entire cell population. These 2 assay 
systems which, in our opinion, mimic more closely conditions 
prevailing within tissues, were used to examine the biological 
properties of the factors reported to be chemotactic for eosin-
ophils. The results presented here reveal marked differences 
between them and suggest possible reasons for the differential 
accumulation of eosinophils in various disease states. 
MATERIALS AND METHODS 
Preparation of Cells 
Human blood was obtained by venipunctul'e and collected into 
heparinized (10 fLl/ml) plastic tubes. The formed elements were either 
sedimented in the presence of dextran, yielding all white blood ce LIs 
(WBC) in the supernatant, or they were separated into mononuclear 
(MNL) and polymorphonuclear (PMN) leukocytes with FicoLl/ Hy-
paque, as previously described [7]. Eosinophils, obtained from patients 
with atopic or collagen-vascular disease, were still admixed with neu-
trophils by this method. In some experiments, pleural cavity exudates 
from patients with c1u'onic congestive heart failUl'e were used, and 
separation by FicoLl/Hypaque resulted in >98% pUl'e eosinoph ils. 
Chemotactic Facl.ors 
Lymphocyte supernatants containing ESP were obtained by stimu-
lating 1 X 107 guinea-pig spleen ceLIs, suspended in Hanks' medium 
containing 2% feta l calf serum (FCS), for 24 hI' at 37°C, 100% humidi ty, 
5% CO2 [3]. The spleens were from normal animals or from guinea pigs 
previously immunized intraperitoneaLly with 0.5 ml of echinococcus 
(EC) antigen (Serotherapeutisches Institut, Wien, Austria), at 4 weekly 
intervals. The EC antigen (5 fLg/ rnJ ) , concanavalin A, 5 fLg/ml 01' PHA, 
2.5 fLg / rnJ were added to the culture tubes at the time of incubation 0 1' 
1 hI' prior to the end of cu ltw-e. At this time, the tubes were centrifuged 
for 15 min, 500 g, 4°C, and the supernatants were stored in a liquots at 
-80°C until use. Since detectable quantities of ESP are found only 
after a minimum of 1 hr after lymphocyte stimulation, the supernatants 
with antigen added towards the end of the culture served as negative 
controls, and values obtained were always subtracted from those of the 
samples incubated for 24 hr. 
ECF was generated fTom human neutrophils after incubation with 
the calcium ionophore A23187 (Eli Lilly Co, Indianapolis, IN) at 5 X 
10- 7 M 01' with complement-coated zymosan (Zx) , as described previ-
ously [2]. Zas was freshly prepared fo r each experiment by activating 
human serum with zymosan, 9 mg/ ml, at 37°C for 30 min, fo llowed by 
inactivation of the carboxypeptidase B at 63°C for 30 min [8]. N-
formyl-methionyl-phenylalanine (NFMP) peptide was purchased from 
Sigma, Munich, FRG, and the ECF-A tetrapeptide ala-gly-ser-glu was 
bought from Serva, Heidelberg, FRG. 
Chemotaxis 
Two well -established methods were employed to study cell migration 
in agarose, with comparable results. A modification of the Nelson 
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technique [6] was used most frequ ently. Two percent agarose (Beh-
ringwerke, Mru'bllTg, FRG) , dissolved in distilled water, was boiled for 
10 min in a water bath and was then mixed at equal volumes with 
doubly concentrated MEM Dulbecco Medium (Seromed, Munich, 
FRG) containing 20% FCS which had been preheated to 40°C. Six 
millili ters of this mi.xture were placed in plast ic Petri dishes for t issue 
cultul"e (Greiner & Sons, Niirtingen, FRG) (6 cm diam) a nd were 
a llowed to cool for 30-60 min at 4°C for the purpose of solidification. 
With a template, 6 radially arranged rows of 3 holes, each with a 
diameter of 3 mm, were punched into the agar. All the middle holes of 
the 6 rows were fill ed with 10 ,ul of the same cell suspension adjusted to 
1 x 10" cells/ml in Hanks' bulfer (Gibco, Glasgow, GB), supplementJd 
with 10% FCS. T en ,ul of the chemotactic factor were placed in all 6 
outer holes, and 10 ,ul medium control in the inner holes. For chemo-
kinesis experiments, the chemotactic factors were either placed in both 
t he inner and outer holes, or they were incorporated directly (at 10%) 
into the agarose in order to obtain a better non-gradient setting. After 
a n incubation (at 37°C, 5% CO~ a nd 100% humidity) lasting 3 hI' for 
PMN and 18 hr for MNL, unless otherwise specified, the dishes were 
nooded for 30 min in absolute methanol, and for the same time period 
in 37% formaldehyde. The agarose was then removed, a nd the cells 
sticking to the bottom of the plates were stained for 8 min in Mayer's 
hema toxylin, followed by 10 min in chromotrop 2R solution to coun-
te rstain the eosinophils. The distance of the leading front of cells from 
the edge of the middle hole was measUl'ed under the microscope with 
a calibrated ocular piece and expressed in arbitrary uni ts. A equals the 
distance towards the chemotactic factor , B the distance towru'ds the 
buffer. The chemotactic ratio (CR) is the fraction of A over B, and the 
chemotactic difference (CD) is obtained by sub tracting B from A. Each 
result is expressed as the mean of 6, 12, or 18 measurements, ± 1 SD, 
depending on the number of Petri dishes used for one assay. 
In a series of preliminru'y experiments, 0.25% gelatine or 1 % human 
serum a lbumin were used instead of 10% heat-inactivated FCS. Migra-
tion under agru'ose was low with gelatine, and the agru'ose was difficult 
to remove from the dishes at the end of the experinlent. R esul ts with 
albumin and FCS were not sta tis tically different, as has also been noted 
previously by Nelson [6], and FCS was chosen for use throughout the 
experiments. 
The second method, originally developed by Colley to assay for ESP 
activity [3] , incorpora tes packed cells into a 2.4 ~Ll droplet in Ha nks' 
m edium containing 2% FCS and 0.25% agru·ose. Individual droplets ru'e 
placed each in one well of a flat-bottom microtiter plate (3040 Falcon, 
Oxnad, Ca, USA), a nd 0.2 ml of Hanks' medium, alone or diluted 1: 1 
with the test substance, ru'e placed over each hardened droplet. After 
a n incubation, lasting usua lly from 17-24 lu', at 37°C, 5 v CO2, 100% 
humidi ty, the distance from the edge of the droplet to the leading fron t 
of the cells is measured at 4 sites at 90° angles through an inverted 
microscope. The mean of the 4 values obta ined from 5-6 different wells 
with the test substance is divided by the value obtained in the same 
way with medium alone. Resul ts ar e expressed as percentage of migra-
tion stimulation. 
Statistics 
Wi th both assay systems, each sample was tested at least 6 t imes in 
the same assay, and tests were repeated on different days and wi th 
several donor leukocytes. Cells from the sam e donor showed consistent 
r esul ts when tested several days apru·t, although data obtained wi th 
different donors showed at times mal' ked quantitative vru·iations. Re-
sults are expressed as mean ± .1 SD. Statistical significance of differ-
ences between test results was evaluated by the Student t-test and 
expressed as p < 0.05. 
RESULTS 
In a first set of experiments, several cell types were examined 
for their responsiveness towards the different chemotactic fac-
tors. With ECF as chemoattractant, neutrophils and eosinophils 
of more than 10 different donors were always responsive, but 
not then: lymphocytes or monocytes, as had already been noted 
in the Boyden assay [7]. The migratory pattern under agarose 
(Nelson method) with cell suspensions from 3 donors is exem-
plified in Table 1. The WBC which still contain monocytes and 
lymphocytes, moved always sluggishly, compared to purified 
PMN preparations, although only the CD and not the CR 
values were statistically diffel'ent among the 3 groups. The 
PMN fraction containing eosinophils moved a far greater dis-
tance towards ECF than the one containing only neutrophils 
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3.0 ± 1.7 
0.9 ± 0.9 
3.3 ± 1.7 
2.1 ± 1.3 
PMN «1 % eos) 
14.7 ± 2.8 
4.0 ± 1.6 
4.2 ± 1.7 
10.7 ± 2.5 
PMN (25% eos) 
25.0 ± 3.7 
6.0 ± 0.9 
4.2 ± 0.6 
19.0 ± 3.3 
" Whole huma n leukocytes (WBC, 62% neutrophils (PMN) , 8% 
monocytes and 30% lymphocytes), pllTified neutrophils and PMN con-
taining 25% eosinophils (eos) from 3 different donors ru'e used as target 
ceUs. Results ru'e expressed as distance of cells migrating towards the 
chemotactic factor (A) , towards the medium (B) , as the ratio of A over 
B (CR) and as A minus B (CD). The data for the CD of the 3 cell types 
studied were statistically different (p < 0.05). 
TABLE II. Migration o( cells (Nelson method) towards activated 
human serum (Zas) containing CSa with puri(ied human PMN, 
PMN containing 26% eosinophils and purified p eripheral 





as target cells" 
PMN (1 % eos) PMN (26% eos) 
21.5 ± 4.4 18.3 ± 3.6 
5.0 ± 0.8 4.1 ± 0.7 
4.3 ± 0.7 4.6 ± 0.8 
16.5 ± 3.2 14.2 ± 3.4 
" Results are expressed as in Table I. 
MNL 
9.9 ± 2.4 
2.1 ± 0.4 
4.4 ± 1.1 
7.8 ± 2.3 
(p < 0.05). This observation was confll'med in all but the 
eosinophil-rich PMN from 2 donors. 
Table II shows data, representative for 5 experiments, with 
different cell preparations and human Zas instead of ECF as 
chemoattractant. T he CR for PMN, for PMN containing eosin-
ophils and for MNL were always comparable. In contrast to the 
fmdings with ECF (Table I) , cells containing eosinophil did 
not migrate further than the purified neutrophils. Fmthermore, 
MNL also responded to Zas, although the distance of migration 
is smaller than that with PMN (p < 0.05). E>..'periments with 
the Nelson technique, similar to those shown for ECF and Zas, 
were also conducted with NFMP and ESP as chemoattractants. 
Data showing the comparative potency of these 4 factors and 
of the synthetic tetrapeptide are summarized in Fig 1. The data 
are again representative for approximately 10 experiments with 
different donor leukocytes. Optimal concentrations of the fac-
tors, established by dilution curves, were used tru·oughout. 
NFMP (1 x 10- 6 M) tended to be the most active agent, but 
there were no statistical differences between the values for 
NFMP, ECF and Zas. The values with ESP were, on the other 
hand, always much lower, n-respective of the donor leukocytes 
used or the percentage of eosinophils they contained (p < 0.05) . 
ECF, Zas, NFMP, and ESP were also examined for then' 
chemokinetic activity, either by incorporating them into the 
agar or by placing them in both sides of the cells in the agar 
holes (Nelson technique) . With either method, all factors were 
shown to enhance migration of then' target cells, compared to 
buffer controls (data not shown) . 
In contrast to these findings, a synthetic tetrapeptide, re-
ported to represent the eosinophil chemotactic activity of mast 
cells, had no chemotactic or chemokinetic activity for eosino-
phils or neutrophils. A wide range of concentrations (10- 2 to 
10- 10 M) which had previously been reported to yield chemo-
tactic activity for both eosinophils and neutl'ophils [9], was 
repeatedly examined with the other factors by om methods. 
The highest values ever obtained are shown in Fig 1. Even with 
>98% pme eosinophils as target cells, the highest CR at 5 x 
10- 6 M concentrations (1.37 ± 0.39) was not statistically different 
fTom buffer controls (data not shown). 
The cells in the Petri dishes were always stained and exam-
ined under the microscope in order to evaluate the target cell 
specificity and selectivity of the factors. Table III showS' rep-
resentative data with 3 different cell preparations from different 
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FIG 1. Comparison of highest values obtained with the 4 chemotac-
tic factors and the ala-gly-ser-glu peptide (ECF-A) in the Nelson test. 
Optimal concentrations of the factors were determined by dilution 
cW'ves and were found to be 1 x lO- G M for NFMP and 5 x lO- G M for 
ala-gly-ser-glu. The test substances that were generated from serum or 
cells (Zas, ESP, ECF) were found to have their highest activity in the 
undiluted form. Human PMN (26% eos) were used as target cells, and 
results are expressed as the chemotactic difference (CD) between cell 
migration towards the factors and towards buffer alone. 
TABLE III. Differential response of human target cells to 4 different 
chemotactic factors with the Nelson technique 
Cells Chemoattractant 
Original cell counted in 
preparations leading 
front ECF Zas NFMP ESP 
1 PMN,98% PMN fl4 ± 3 100 ± 0 100 ± 0 100 ± 0 
eos, 1% eos 6 ±2 O±O O± O O± O 
eos,28% . eos 63 ± 5 26 ± 4 10 ± 2 25 ± 3 
II (PMN,75%) PMN 36 ± 4 74 ± 3 88 ± 3 76 ± 4 
MNL 
1II mono, 33% mono O±O 100 ± 0 n.d . O±O 
lymph, 64% lymph O± O o±o n.d. O±O 
" Representative data with 3 different cell preparations from different donors 
are shown (PMN = purified neutrophils, MNL = mononuclear cells, eos = 
eosinophils, mono = monocytes, lymph = lymphocytes). The percentage of cells 
in the area closest to the chemotactic factor is recorded. Note the selectivity of 
ECF for eosinophils. n.d. = not done. 
starting hole towards the_ chemotactic factor, the ones in the 
distal half of the migration areas were counted and differen-
tiated. As can be seen in the Table, all chemoattractants tested 
were active towards neutrophils, only Zas was active towards 
monocytes, and lymphocytes did not respond at all. Zas and 
ESP were equally chemotactic for neutrophils as for eosino-
phils, while ECF was very selective for eosinophils. NFMP 
showed a preference for neutrophils over eosinophils. In fact, 
the percentage of eosinophils strikingly increased among the 
cells closest to the buffer containing B hole. 
The readings of the migration distance taken at different 
times after incubation disclosed marked differences in the ki-
netics of responsiveness of the different cells to the ch emotactic 
factors. Fig 2 shows data on ECF and Zas in the agarose 
microdroplet test, with 99% PMN as target cells. The cells 
reached their maximal migration distance within the first 10 hI', 
and after that, leveled off or fell even below the distance reached 
by cells incubated in buffer alone. Similar data were obtained 
when 20-98% eosinophils, admixed with the PMN, were used 
as target cells (not shown). 
ESP and NFMP, tested against >98% human eosi'nophils 
(Fig 3), showed very different kinetics. ESP caused a gradual 
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FIG 2. Kinetics experiments comparing the responsiveness of pW'i-
fied human PMN to ECF and Zas at different time intervals in the 
agarose microdl'Oplet assay. Results show the mean of 16 values ± 1 
SD of the migration distances measured minus the distance obtained 
with cells incubated in buffer alone. (CD = chemotactic difference) . 
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FIG 3. Kinetics of eosinophil (>98% purified cells) migration in 
response to ESP and NFMP in the agarose microdroplet assay. ESP 
was generated from lymphocytes with Con A, 5 Ilg/ml as stimulus. 
Identical results were obtained with ESP generated from lymphocytes 
during incubation with PHA or echinococcus antigen. Note the lack of 
responsiveness of human eosinophils to NFMP. For methods, see 
Fig 2. 
increase of the chemotactic distance, with maximal values 
between 30 to 40 hr after incubation. NFMP was ineffective 
with eosinophils, but in experiments with neutrophil prepara-
tions from 4 different donors, it paralleled yet exceeded the 
activity of ESP on a quantitative basis (not shown) . 
DISCUSSION 
The results reported here provide, for the first time, compar-
ative data on the biological behavior of several well-known 
eosinophil chemotactic factors . They confIrm that all but the 
peptide ala-gly-ser~glu are chemotactic and chemokinetic for 
neutrophils, that ECF h as a high selectivity for eosinophils 
(Table III), that NFMP does not attract eosinophils at all 
(Table III, Fig 3) and that ESP and Zas work on eosinophils as 
well as on neutrophils. The selectivity of ECF for eosinophils 
has been reported by us with both the Boyden chamber assay 
[7] and by in vivo methods [10]. Weller, Dvorak, and White-
house [11] had noted a preference for eosinophils with ESP as 
well, but this was not found by the authors who originally 
described the ESP [3]. 
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Zas, containing C5a as chemotactic factor, has the broadest 
range of target cell specificity. The response of these cells 
towards NFMP has also been reported by Nelson, McCormack, 
and Fiegel [12]. The same authors also reported on the lack of 
activity with lymphocytes in their test system. The congruence 
of our findings with those in the literature for these cell types 
support therefore our observation with the eosinophils as target 
cells and with the eosinophil chemotactic factors not tested by 
these workers. 
The mechanisms underlying the selectivity of ECF for eosin-
ophils are unclear. One reason may be an increased number of 
membrane receptors for ECF on eosinophils, another a selective 
increase of the metabolic activity of eosinophils in the presence 
of ECF. The importance of ECF in the preferential accumula-
tion of eosinophils is underlined by the presence of the factor in 
serum and in tissues [Tom patients with eosinophilia [13-15]. 
Mononuclear leukocytes migrate substantially less than 
PMNs (Table II), and their presence among responding cells 
may even be inhibitory (Table I). These findings could be due 
to an inherently slower responsiveness of the MNL to the 
chemotactic stimuli, such as a greater sluggishness of their 
cytoskeletal machinery. A further possible explanation may be 
the secretion of lymphocyte products such as migration inhib-
itory substance (MIF) [16] or leukocyte inhibitory substance 
(LIF) [17] in the specific experimental setting. The presence of 
these substances in the ESP-containing lymphocyte superna-
tants may also explain the lower potency of the ESP compared 
to the other 3 factors (Fig. 1). Taken together, these different 
mechanisms could account for the delayed appearance of MNL 
during inflammatory processes at tissue sites. 
The potency of the factors, as shown in Fig 1, fits with data 
reported by Nelson et al for Zas and NFMP [12]. They show, 
in addition, that ECF is of comparable potency and that ESP 
is less potent. These data must be viewed with caution since 
donor leukocytes vary considerably among each other and even 
from day to day with regard to their chemotactic responsive-
ness. Nevertheless, the values shown are representative for 
more than 10 different donors tested, and they agree with 
observations reported by others and with our own data in 
Boyden chambers. Furthermore, although Zas, ESP and ECF 
are crude mixtures compared to the bacterial factor analogue 
NFMP and the ala-gly-ser-glu peptide, they represent the ma-
terial as it also occurs in the tissue. ESP is known to be a 
peptide (24,000-56,000 dalton) [18], but has not yet been totally 
isolated. The same holds for ECF which is a lipid (~500 dalton) 
closely related to the leukotrienes [19]. C5a is again a peptide 
(~12,500) which has recently been isolated by one la boratory 
[20], but is not yet available to other groups in this pUJ"ified 
form. Hugli has reported that human C5a and NFMP have 
comparable activities for neutrophils on a quantitative basis.' 
The divergent kinetics for ESP, Zas and ECF, as shown in 
Figs 2 and 3, have not hitherto been reported. The fast activity 
of ECF and Zas would fit with the rapid mode of generation of 
these factors within seconds from leukocytes [7] or complement 
components [20] and with the more sluggish production of 
lymphokines [3]. The decreased activity of both ECF and Zas 
at later time intervals may be explained by the documented 
destruction of the molecules by leukocyte pl'oducts on extended 
incubation [20, 21). 
As a final point, it should be emphasized that the data on the 
different biological activities of the eosinophil chemotactic fac-
tors reported here could not have been obtained with conven-
tional Boyden chamber assays. Apart from the fact that the 
differentiation of eosinophils and neutrophils is more easily 
accomplished, the agarose supplies an equal resistance to all 
migl'ating cells. The filters used in the Boyden chamber have 
to be used with different sized holes for different cell types, so 
that the smaller holes for neutrophils provide an artificial 
impedinlent to the larger sized eosinophils and monocytes. 
* Federation meetings, Atlanta, 1981, oral presentation. 
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Further, in the Boyden chamber, adherence to the lower side 
of the ftlter and drop-off of the cells are factors that influence 
the readings and make an adequate evaluation of the differen-
tial migratory behavior of a mixed population as well as the 
kinetics of migration of these cells difficult to obtain. 
Besides the factors studied here, there have been others 
reported to have eosinophil chemotactic activity. The most 
interesting among them al'e extracts of pal'asites [3,22]. We 
have tested such matel'ial from larvae and adult worms of 
Nippostrongylus brasiliensis and have found only chemoki-
netic but not chemotactic activity for eosinophils of sensitized 
animals [23]. The factors examined in this study worked, on 
the other hand, independent of the specific state of immuniza-
tion of the person. Their presence in val'ious types of inflam-
matory reactions may, on the basis of their divergent modes of 
generation and their different biological activities, well explain 
the different cellular reaction patterns associated with eosino-
phil infiltrates at tissue sites. 
The authors wish to express their gratitude for t he technical and 
secretarial help of Ms. A. Feldmann, Ms. B. Unnerstall and Ms. M. H. 
MUlTay. 
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The Effect of Accumulated Lipids on Measurements of Sebum Secretion 
in Human Skin 
DONALD T. DOWNING, PH.D., ANNA M. STRANIERI, B.S., AND JOHN S . STRAUSS, M.D. 
The Marshall Dermatology Research Laboratories, Department of Dermatology, University of Iowa College of Medicine, Iowa 
City, Iowa, U.S.A .. 
When sebum is collected from the skin surface in an 
absorbent material, the amounts obtained in successive 
collections at the same site decline steadily. In the pres-
ent study, sebum was a bsorbed into b entonite clay ap-
plied to 2.5 sq cm areas on the foreheads of 3 subjects for 
3-hr intervals during 24 hr. The amounts of sebum ob-
tained, measured by thin-layer chromatography, de-
clined for 12 hr and then remained constant for the 
r emaining 12 hr. It was inferred that the final, sustain-
able rate represents the true rate at which sebum was 
being secreted by the sebaceous glands, and that the 
additional sebum collected at earlier intervals was ob-
tained from an accumulation in the stratum corneum or 
in the follicular canals. For the 3 subjects, the accumu-
lated sebum averaged 213 /Lg/sq cm, compared with a 
sustainable secretion rate of 25 /Lg/sq cm/hr. The large 
quantity of accumulated sebum, relative to the secretion 
rate, could obscure differences between subjects when 
sebum secretion rates are measured by short-term col-
lections of sebum in absorbent materials. 
We have recently had reason to consider whether the pilo-
sebaceous canals or the lipid-filled intercellular spaces of the 
stratum corneum [1-5] might provide for the accumulation of 
significant amounts of sebum aft er its secretion by the seba-
ceous glands. Such a possibility could explain the observation 
that absorbent materials placed on the skin surface continue 
for many hours to accumulate sebum at rates greater than that 
at which it is secreted. Thus, in the technique for measuring 
sebum production rates developed by Strauss and Pochi [6], 
sheets of absorbent paper are held tightly to the prepared skin 
surface for 3 hr. The sebum absorbed is then extracted and 
weighed to provide a measure of sebum secretion rate. However, 
if another set of papers is immediately applied to the site for an 
additional 3-hr period, the amount of sebum collected is always 
considerably less [7], an observation which we have confirmed 
but previously have been unable to explain. 
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In the present study, we have used films of bentonite clay 
applied to the skin for the purpose of sebum absorption, ex-
pecting that the more intimate surface contact and greater 
absorbency of this material might provide for more rapid and 
quantitative collection of sebum from the skin surface. The use 
of thin-layer chromatography to quantify the sebum collected 
allowed the use of smaller and more numerous collection sites, 
due to the ability of the quantifying procedure to accurately 
measure small amounts of sebum. As a result of these studies, 
we have been able to confirm the depletion phenomenon ob-
served with the paper absorption method, and to show that this 
could be due to an accumulation of sebum in some cutaneous 
compartment. 
METHODS 
Sebum Absorption into Paper 
The technique used was that of Strauss and Pochi [6]. An area 1" 
x 3/4" in the center of the forehead was outlined with nonperforated 
adhesive surgical tape, a nd then pads of ether-extracted cigal·ette 
papers were applied and held in place with a gauze pad and an elastic 
bandage. After 2 successive 15-min coUection periods, fTesh papers were 
applied for ea·ch of 2 successive 3-hr intervals. After removal, the 
collected sebum was elu ted with ether into preweighed aluminum foil 
cups, the ether was evaporated on a slide warmer, and the rema ining 
sebum was weighed. 
Sebum Absorption into Bentonite Clay 
The subject's forehead was washed thoroughly with soap and water 
and then rinsed clean with water. This process was repeated, and then 
the skin was dried with a paper towel. A film of an aqueous gel 
containing 15% bentonite clay and 0.2% carboxymethyl cellulose was 
applied to the skin and then 1.8 cm dia. discs cut from fine Dacron 
mesh (Cistron Corp., Lebanon, PA, catalog #678-149) were pressed into 
the film and smoothed over with additional gel. These films dried to an 
adherent, oil-absorbing layer in about 10 min. After the required 
collection time, the area of clay defined by a disc was peeled off a nd 
placed in 5 ml of ether for extraction of the lipids. The bared area of 
the skin was then treated with ano ther film of the gel and a fresh disc. 
The ent ire procedure was repeated as often as required by the experi-
mental protocol. 
The amount and composition of sebum extracted fTom the clay on 
each occasion were measUl·ed by quantitative thin-layer chromatogra-
phy [8,9]. Thus, each ether extract was evaporated and the lipid residue 
was redissolved in 100 fLl of to luene. A 4 1'1 a liquot of each solu t ion was 
applied with a micropipet (Drummond Microcap) to a 6 mm-wide lane 
scribed in a 250 I'm layer of silica gel G on a 20 x 20 cm glass plate. 
S imilarly, a 4 1'1 aliquot of a solut ion of steru·yl oleate in toluene (2 mg/ 
